BioSig Technologies, Inc. STEX Corporate — Income Tax Expense Benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s corporate — income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s corporate — income tax expense benefit?
- BioSig Technologies, Inc. (STEX) reported corporate — income tax expense benefit of $565K in Q1 2026.
- What does corporate — income tax expense benefit mean?
- This metric reflects the provision for income taxes or the recognition of tax benefits attributable to the corporate segment's operations. It represents the impact of tax regulations on the segment's net financial results after accounting for applicable tax jurisdictions.